Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Pharmacogenetics and Genomics|October 22, 2013
Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatmentBritt I Drögemöller, Galen E B Wright, Dana J H Niehaus, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary studyRobin Emsley, Rossella Medori, Liezl Koen, et al.
Psychiatry Research|February 16, 2018
Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohortNathaniel McGregor, Nicole Thompson, Kevin Sean O'Connell, et al.
Global Mental Health (Cambridge, England)|May 27, 2026
Beyond treatment non-adherence: A qualitative study of clinicians' perspectives on structural and social determinants of schizophrenia relapse in South AfricaAnna Margaretha Smit, Sanja Kilian, Hilmar Klaus Luckhoff, et al.
Early Intervention in Psychiatry|January 3, 2022
Hair cortisol levels in schizophrenia and metabolic syndromeLeigh Luella van den Heuvel, Anna Margaretha Smit, Tobias Stalder, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Remission in first-episode psychosis: predictor variables and symptom improvement patternsRobin Emsley, Piet P Oosthuizen, Martin Kidd, et al.
Early Intervention in Psychiatry|April 3, 2014
Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained settingBonginkosi Chiliza, Akin Ojagbemi, Oluyomi Esan, et al.
The South African Journal of Psychiatry : SAJP : the Journal of the Society of Psychiatrists of South Africa|September 29, 2018
Cognitive-perceptual deficits and symptom correlates in first-episode schizophreniaRiaan M Olivier, Sanja Kilian, Bonginkosi Chiliza, et al.
Schizophrenia Research|December 7, 2007
Deficits in facial affect recognition in unaffected siblings of Xhosa schizophrenia patients: evidence for a neurocognitive endophenotypeJukka M Leppänen, Dana J H Niehaus, Liezl Koen, et al.
International Clinical Psychopharmacology|October 16, 2008
Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studiesRobin Emsley, Joris Berwaerts, Mariëlle Eerdekens, et al.
Pageof 15